Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology

作者: C. J. Knight , A. D. Timmis

DOI: 10.1136/HEARTJNL-2011-300979

关键词:

摘要: This overview highlights some recent advances in the epidemiology, diagnosis, risk stratification and treatment of acute coronary syndromes. The sheer volume new studies reflects robust state global cardiovascular research but focus here is on findings that are most interest to practising cardiologist. Incidence mortality rates for myocardial infarction decline, probably owing a combination lifestyle changes, particularly smoking cessation, improved pharmacological interventional treatment. Troponins remain central diagnosis high-sensitivity assays further lowering detection thresholds improving outcomes. incremental diagnostic value other circulating biomarkers remains unclear simple clinical algorithms such as GRACE score have proved more useful. Primary PCI with minimal delay effective reperfusion strategy ST elevation (STEMI). Radial access associated less bleeding than femoral approach, outcomes appear similar. Manual thrombectomy limits distal embolisation infarct size while drug-eluting stents reduce need revascularisation procedures. Non-culprit disease best dealt electively staged procedure after primary has been completed. development antithrombotic antiplatelet regimens continues evolve, indications fondaparinux bivalirudin well small-molecule glycoprotein (GP)IIb/IIIa inhibitors. If timely unavailable, fibrinolytic an option early angiographic assessment recommended all patients. Non-ST segment (NSTEMI) now dominant phenotype phase significantly worse STEMI. Many patients NSTEMI undertreated there large body work seeking define this group patients. benefits invasive …

参考文章(104)
Ran Kornowski, Roxana Mehran, George Dangas, Eugenia Nikolsky, Abid Assali, Bimmer E Claessen, Bernard J Gersh, S Chiu Wong, Bernhard Witzenbichler, Giulio Guagliumi, Dariusz Dudek, Martin Fahy, Alexandra J Lansky, Gregg W Stone, HORIZONS-AMI Trial Investigators, Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction : Analysis From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial Journal of the American College of Cardiology. ,vol. 58, pp. 704- 711 ,(2011) , 10.1016/J.JACC.2011.02.071
Sanjit S Jolly, David P Faxon, Keith AA Fox, Rizwan Afzal, William E Boden, Petr Widimsky, P Gabriel Steg, Vicent Valentin, Andrez Budaj, Christopher B Granger, Campbell D Joyner, Susan Chrolavicius, Salim Yusuf, Shamir R Mehta, None, Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. Journal of the American College of Cardiology. ,vol. 54, pp. 468- 476 ,(2009) , 10.1016/J.JACC.2009.03.062
Yariv Gerber, Laura J Rosen, Uri Goldbourt, Yael Benyamini, Yaacov Drory, Israel Study Group on First Acute Myocardial Infarction, Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. Journal of the American College of Cardiology. ,vol. 54, pp. 2382- 2387 ,(2009) , 10.1016/J.JACC.2009.09.020
Angela Migliorini, Amerigo Stabile, Alfredo E Rodriguez, Caterina Gandolfo, Alfredo M Rodriguez Granillo, Renato Valenti, Guido Parodi, Franz-Josef Neumann, Antonio Colombo, David Antoniucci, JETSTENT Trial Investigators, Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. Journal of the American College of Cardiology. ,vol. 56, pp. 1298- 1306 ,(2010) , 10.1016/J.JACC.2010.06.011
Uwe Zeymer, Alain Margenet, Michael Haude, Christoph Bode, Jean-Marc Lablanche, Hubertus Heuer, Rolf Schröder, Stefan Kropff, Ryad Bourkaib, Norbert Banik, Ralf Zahn, Emmanuel Teiger, Randomized Comparison of Eptifibatide Versus Abciximab in Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction: Results of the EVA-AMI Trial Journal of the American College of Cardiology. ,vol. 56, pp. 463- 469 ,(2010) , 10.1016/J.JACC.2009.08.093
Axel Åkerblom, Stefan K James, Michail Koutouzis, Bo Lagerqvist, Ulf Stenestrand, Bodil Svennblad, Jonas Oldgren, None, Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Journal of the American College of Cardiology. ,vol. 56, pp. 470- 475 ,(2010) , 10.1016/J.JACC.2009.10.093
Pieter J. Vlaar, Karim D. Mahmoud, David R. Holmes, Gert van Valkenhoef, Hans L. Hillege, Iwan C.C. van der Horst, Felix Zijlstra, Bart J.G.L. de Smet, Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. Journal of the American College of Cardiology. ,vol. 58, pp. 692- 703 ,(2011) , 10.1016/J.JACC.2011.03.046
Gennaro Sardella, Massimo Mancone, Chiara Bucciarelli-Ducci, Luciano Agati, Raffaele Scardala, Iacopo Carbone, Marco Francone, Angelo Di Roma, Giulia Benedetti, Giulia Conti, Francesco Fedele, Thrombus Aspiration During Primary Percutaneous Coronary Intervention Improves Myocardial Reperfusion and Reduces Infarct Size: The EXPIRA (Thrombectomy With Export Catheter in Infarct-Related Artery During Primary Percutaneous Coronary Intervention) Prospective, Randomized Trial Journal of the American College of Cardiology. ,vol. 53, pp. 309- 315 ,(2009) , 10.1016/J.JACC.2008.10.017
Mark J. Sculpher, Greta Lozano-Ortega, Jennifer Sambrook, Stephen Palmer, Orges Ormanidhi, Ameet Bakhai, Marcus Flather, P. Gabriel Steg, Shamir R. Mehta, William Weintraub, Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. American Heart Journal. ,vol. 157, pp. 845- 852 ,(2009) , 10.1016/J.AHJ.2009.02.017